Go offline with the Player FM app!
Live from ASRM 2023: Part 2 - More Science and The ASRM Mission
Manage episode 382706574 series 2794592
Fertility & Sterility on Air brings you some great interviews from ASRM 2023 in New Orleans, LA! In Part 2, we bring you some more science, including the first prize paper and discussion with two of our plenary speakers, followed by a focus on the ASRM mission. Topics include: clinical outcomes of mosaic embryo transfers (Manuel Viotti, Svetlana Madjunkova) (1:17), the potential for anti-mullerian hormone as a novel contraceptive (David Pépin) (14:59), a bioengineering approach to the study of endometriosis and adenomyosis (Linda Griffith) (24:10), plans for a year of equity, access, and innovation with new ASRM president Paula Amato (31:34), and Michael Simoni introducing the medical students in the ASRM Career Pathways Program (42:08).
View Fertility and Sterility at https://www.fertstert.org/
117 episodes
Manage episode 382706574 series 2794592
Fertility & Sterility on Air brings you some great interviews from ASRM 2023 in New Orleans, LA! In Part 2, we bring you some more science, including the first prize paper and discussion with two of our plenary speakers, followed by a focus on the ASRM mission. Topics include: clinical outcomes of mosaic embryo transfers (Manuel Viotti, Svetlana Madjunkova) (1:17), the potential for anti-mullerian hormone as a novel contraceptive (David Pépin) (14:59), a bioengineering approach to the study of endometriosis and adenomyosis (Linda Griffith) (24:10), plans for a year of equity, access, and innovation with new ASRM president Paula Amato (31:34), and Michael Simoni introducing the medical students in the ASRM Career Pathways Program (42:08).
View Fertility and Sterility at https://www.fertstert.org/
117 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.